Cite
MLA Citation
T. Facon et al.. “P936: TIME TO RESPONSE, DURATION OF RESPONSE, AND PATIENT-REPORTED OUTCOMES WITH DARATUMUMAB PLUS RD VS RD ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NDMM: SUBGROUP ANALYSIS OF THE PHASE 3 MAIA STUDY.” HemaSphere, vol. 6, n.d., pp. 826–827. http://access.bl.uk/ark:/81055/vdc_100159756651.0x000005